Literature DB >> 24297593

Cerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: our experience and literature review.

Felice D'Arco1, Alessandra D'Amico, Ferdinando Caranci, Nilde Di Paolo, Daniela Melis, Arturo Brunetti.   

Abstract

PURPOSE: Neurofibromatosis type 1 (NF1) is a multisystem autosomal dominant disorder that primarily involves the skin and the nervous system. Development of cerebral arterial stenosis is a potentially deadly complication of NF1, which is frequently underestimated. The aim of our paper is to report the frequency of this cerebrovascular disease in a series of patients affected by NF1, using magnetic resonance angiography (MRA). A review of the literature was also performed, focused on the usefulness of MRA in NF1 patients.
MATERIALS AND METHODS: Among 125 patients with NF1 (clinical diagnosis according to the standard National Institutes of Health criteria), 81 (65%) were studied with brain MRI (magnetic resonance imaging) and MRA using a 1.5 T magnet.
RESULTS: Multiple intracranial arterial stenoses were found in six patients (7.4%). In our study, MRA proved to be critical, especially for the detection of stenoses in the branches of the Circle of Willis.
CONCLUSION: Few case series have investigated the incidence of vascular complications of NF1, and most of them have used MRI. We suggest adding MRA to the brain imaging of all these patients, as stenoses of the branches of the Circle of Willis are often undetectable by MRI only.

Entities:  

Mesh:

Year:  2013        PMID: 24297593     DOI: 10.1007/s11547-013-0358-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  29 in total

1.  Cerebral vasculopathy in children with neurofibromatosis type 1.

Authors:  Partha S Ghosh; A David Rothner; Todd M Emch; Neil R Friedman; Manikum Moodley
Journal:  J Child Neurol       Date:  2012-04-24       Impact factor: 1.987

2.  Novel mutation of neurofibromatosis type 1 in a patient with cerebral vasculopathy and fatal ischemic stroke.

Authors:  Sung-Chun Tang; Ming-Jen Lee; Jiann-Shing Jeng; Ping-Keung Yip
Journal:  J Neurol Sci       Date:  2006-01-18       Impact factor: 3.181

3.  Moyamoya syndrome associated with neurofibromatosis type I in a pediatric patient.

Authors:  Luiz Guilherme Darrigo Júnior; Elvis Terci Valera; André de Aboim Machado; Antonio Carlos Dos Santos; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Sao Paulo Med J       Date:  2011-03       Impact factor: 1.044

4.  Indirect bypass procedures for moyamoya disease in pediatric patients.

Authors:  Tuncer Turhan; Yusuf Erşahin
Journal:  Turk Neurosurg       Date:  2011       Impact factor: 1.003

5.  The cost of pediatric stroke care and rehabilitation.

Authors:  Warren Lo; Khaled Zamel; Kavita Ponnappa; Antoni Allen; Deena Chisolm; Monica Tang; Bryce Kerlin; Keith O Yeates
Journal:  Stroke       Date:  2007-11-21       Impact factor: 7.914

6.  The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas.

Authors:  Kavita K Mishra; Dev R Puri; Brian T Missett; Kathleen R Lamborn; Michael D Prados; Mitchel S Berger; Anuradha Banerjee; Nalin Gupta; William M Wara; Daphne A Haas-Kogan
Journal:  Neuro Oncol       Date:  2006-02-22       Impact factor: 12.300

7.  Spectrum and prevalence of vasculopathy in pediatric neurofibromatosis type 1.

Authors:  Bonnie Kaas; Thierry A G M Huisman; Aylin Tekes; Amanda Bergner; Jaishri O Blakeley; Lori C Jordan
Journal:  J Child Neurol       Date:  2012-07-25       Impact factor: 1.987

8.  Epidemiology and genetics of intracranial aneurysms.

Authors:  F Caranci; F Briganti; L Cirillo; M Leonardi; M Muto
Journal:  Eur J Radiol       Date:  2013-02-08       Impact factor: 3.528

9.  Structural anomalies revealed by neuroimaging studies in the brains of patients with neurofibromatosis type 1 and large deletions.

Authors:  B R Korf; G Schneider; T Y Poussaint
Journal:  Genet Med       Date:  1999 May-Jun       Impact factor: 8.822

Review 10.  Neurofibromatosis type 1 revisited.

Authors:  Virginia C Williams; John Lucas; Michael A Babcock; David H Gutmann; Bruce Korf; Bernard L Maria
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

View more
  6 in total

1.  Olfactory bulb enlargement in neurofibromatosis type 1: report of a novel finding.

Authors:  Alessandra D'Amico; Martina Di Stasi; Lorenzo Ugga; Teresa Perillo; Claudia Santoro; Daniela Melis
Journal:  Childs Nerv Syst       Date:  2021-02-10       Impact factor: 1.475

2.  Nf1+/- monocytes/macrophages induce neointima formation via CCR2 activation.

Authors:  Waylan K Bessler; Grace Kim; Farlyn Z Hudson; Julie A Mund; Raghuveer Mali; Keshav Menon; Reuben Kapur; D Wade Clapp; David A Ingram; Brian K Stansfield
Journal:  Hum Mol Genet       Date:  2016-01-05       Impact factor: 6.150

3.  Whole spine MRI is not required in investigating uncomplicated paediatric lumbosacral lipoma. A retrospective single-institution review.

Authors:  Hugo Layard Horsfall; Aswin Chari; Terhi Huttunen; Clare Simcock; Felice D'Arco; Dominic Thompson
Journal:  Childs Nerv Syst       Date:  2019-09-09       Impact factor: 1.475

4.  Synergistic Interplay between Curcumin and Polyphenol-Rich Foods in the Mediterranean Diet: Therapeutic Prospects for Neurofibromatosis 1 Patients.

Authors:  Teresa Esposito; Carla Schettino; Paola Polverino; Salvatore Allocca; Laura Adelfi; Alessandra D'Amico; Guglielmo Capaldo; Bruno Varriale; Anna Di Salle; Gianfranco Peluso; Giuseppe Sorrentino; Giacomo Lus; Simone Sampaolo; Giuseppe Di Iorio; Mariarosa Anna Beatrice Melone
Journal:  Nutrients       Date:  2017-07-21       Impact factor: 5.717

Review 5.  Recent Advances in the Diagnosis and Pathogenesis of Neurofibromatosis Type 1 (NF1)-associated Peripheral Nervous System Neoplasms.

Authors:  Jody F Longo; Shannon M Weber; Brittany P Turner-Ivey; Steven L Carroll
Journal:  Adv Anat Pathol       Date:  2018-09       Impact factor: 4.571

6.  Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.

Authors:  Alessandra D'Amico; Lorenzo Ugga; Sirio Cocozza; Sara Maria Delle Acque Giorgio; Domenico Cicala; Claudia Santoro; Daniela Melis; Giuseppe Cinalli; Arturo Brunetti; Sabina Pappatà
Journal:  Neurol Sci       Date:  2020-07-10       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.